Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to the emergency department

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 10, 2014, Pages 1465-1472

  Magrini, Laura ^a   Gagliano, Giulia ^b   Travaglino, Francesco ^b   Vetrone, Francesco ^b   Marino, Rossella ^b   Cardelli, Patrizia ^b   Salerno, Gerardo ^b   Di Somma, Salvatore ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

C reactive protein; Diagnosis; Emergency department; Infection; Procalcitonin; Prognosis; White blood cells

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

AGED; APACHE; ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DEATH; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HUMAN; INTERRATER RELIABILITY; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; BLOOD; EMERGENCY HEALTH SERVICE; METABOLISM; REPRODUCIBILITY;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PROGNOSIS; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; SEPSIS;

EID: 84921341828     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0210     Document Type: Article

References (35)

1. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther 2012;10:701-6.
2. Knaus WA, Sun X, Nystrom O, Wagner DP. Evaluation of definitions for sepsis. Chest 1992;101:1656-62.
3. Maseda E, Mensa J, Valía JC, Gomez-Herreras JI, Ramasco F, Samso E, et al. Bugs, hosts and ICU environment: countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting. Rev Esp Quimioter 2013;26:312-31.
4. Rohde JM, Odden AJ, Bonham C, Kuhn L, Malani PN, Chen LM, et al. The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit. J Hosp Med 2013;8:243-7.
5. Balk RA, Bone RC. The septic syndrome: definition and clinical implications. Crit Care Clin 1989;5:1-8.
6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
7. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
8. Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8.
9. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013;50: 23-36.
10. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010;14:R15.
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign guidelines committee including the pediatric subgroup. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Intens Care Med 2013;39:165-228.
12. Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011;66(Suppl 2):ii33-40.
13. Derlet RW, Richards JR. Overcrowding in the nation's emergency departments: complex causes and disturbing effects. Ann Emerg Med 2000;35:63-8.
14. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014;5:219-25.
15. Jaimes FA, De La Rosa GD, Valencia ML, Arango CM, Gomez CI, Garcia A, et al. A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis. BMC Anesthesiol 2013;13:23.
16. Park M, Azevedo LC, Maciel AT, Pizzo VR, Noritomi DT, Cruz Neto LM. Evolutive standard base excess and serum lactate level in severe sepsis and septic shock patients resuscitated with early goal-directed therapy: still outcome markers? Clinics 2006;61:47-52.
17. Angele MK, Frantz MC, Chaudry IH. Gender and sex hormones influence the response to trauma and sepsis - potential therapeutic approaches. Clinics 2006;61:479-88.
18. Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care 2002;6(Suppl 3):S1-18.
19. Crea F, Biasucci LM. Innate immune inflammatory response to danger: when, how, and why does a friend become a foe? Eur Heart J 2012;33:1434-7.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
21. Horwitz LI, Green J, Bradley EH. US Emergency department performance on wait time and length of visit. Ann Emerg Med 2010;55:133-41.
22. Rink L, Cakman I, Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev 1998;102:199-209.
23. Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004;39:687-99.
24. Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC. Diagnostic value of procalcitonin for bacterial infection in elderly patients, a systemic review and meta-analysis. Int J Clin Pract 2013;67:1350-7.
25. Loonen AJ, de Jager CP, Tosserams J, Kusters R, Hilbink M, Wever PC, et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One 2014;9:e87315.
26. Arai T, Kumasaka K, Nagata K, Okita T, Oomura T, Hoshiai A, et al. Prediction of blood cultures results by measuring procalcitonin levels and other inflammatory biomarkers. Am J Emerg Med 2014;32:330-3.
27. Innocenti F, Bianchi S, Guerrini E, Vicidomini S, Conti A, Zanobetti M, et al. Prognostic score for early stratification of septic patients admitted to an emergency department-high dependency unit. Eur J Emerg Med 2013 Aug 21. [Epub ahead of print].
28. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:234-42.
29. Meidani M, Khorvash F, Abolghasemi H, Jamali B. Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer 2013;2:216-9.
30. Magrini L, Travaglino F, Marino R, Ferri E, De Berardinis B, Cardelli P, et al. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases. Eur Rev Med Pharmacol Sci 2013;17(Suppl 1):133-42.
31. Tang H, Jing J, Bo D, Xu D. Biological variations of leukocyte numerical and morphologic parameters determined by UniCelDxH 800 hematology analyzer. Arch Pathol Lab Med 2012;136:1392-6.
32. Caruso C, Buffa S, Candore G, Colonna-Romano G, Dunn-Walters D, Kipling D, et al. Mechanisms of immunosenescence. Immun Ageing 2009;6:10.
33. Falci C, Gianesin K, Sergi G, Giunco S, De Ronch I, Valpione S. Immune senescence and cancer in elderly patients: results from an exploratory study. Exp Gerontol 2013;48:1436-42.
34. Prkno A, Wacker C, Brunhorst FM, Schlattman P. Procalcitoninguided therapy in intensive care unit patients with severe sepsis and septic shock - a systematic review and meta-analysis. Crit Care 2013;17:R291.
35. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, et al. Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med 2013;51:1167-75.